Globes [online] reports:
Remon Medical’s technology is integrated into minute implants, requiring no antenna, wires, or connecting leads, that allow a tiny device implanted deep inside the body to communicate wirelessly with other implanted devices and external systems.
Remon Medical continues its clinical trial of the Remon Impressure, a device that offers on-demand, non-invasive means to monitor intra-aneurysm pressures following endo-vascular graft procedures. The device was implanted and is being used successfully in 21 patients in the Mount Sinai Hospital in New York.
Remon Medical also develops the Remon HeartLook, a device for measurement of pulmonary artery pressure, which is the most important hemodynamic indicator in heart failure. A one-time, minimally invasive catheter-based procedure allows HeartLook unlimited, non-invasive home-based monitoring of a CHF patient’s hemodynamic status.
So how does the company’s technology work? The website of Remon Medical of Caesarea, Israel describes the proprietary technology:
The Company’s core technology utilizes acoustic waves, which both energize and communicate with the implanted device. The advantage of this approach is that acoustic waves transmit effectively inside the body (through soft tissue, bones and fluids), and are not absorbed by the intervening tissue. Acoustic communication requires very little energy to achieve a high signal-to-noise ratio when accessing locations deep inside the body.
The implant is energized and activated on-demand via an external transducer. The implant converts the acoustic waves into electrical energy via its proprietary energy exchanger.
As the system’s internal transducer operates at a low resonance frequency, Remon’s implant is omni-directional, insensitive to the exact direction of the external transducer.
More coolness at Remon Medical…